YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
St. Louis biotech startup Arch Oncology raised $105 million in a funding round.
The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.
Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.
Read more from the St. Louis Business Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects